PROVEN MEDICINES ... SAFER THERAPIES
corporate overview
technology
investor relations
news/events
contact us
For more information about KemPharm please visit our technology section.
Latest developments at KemPharm can be found by clicking on
News
.
News/events
Press Releases
6/23/2010
KemPharm, Inc. Appoints Todd Johnson, Ph.D. as Chief Commercial Officer
5/18/2010
KemPharm, Inc. Announces Entering Into an Exclusive Supply Agreement With Johnson Matthey Inc. for KP201
1/11/2010
KemPharm, Inc. Announces Positive Results from Phase 1 Trial of KP106 for ADHD
10/22/2009
KemPharm, Inc. Announces Initiation of Phase 1 Trial of KP106 for ADHD
9/16/2009
KemPharm, Inc. Expands Prodrug Pipeline with Candidate for Treatment of Pain and Closes Series B Financing
KemPharm News
4/6/2010
The Technology Association of Iowa (TAI) Announces the 2010 Prometheus Award Winners
11/11/2009
KemPharm's Vice President of Corporate Affairs honored with Iowa's Women of Innovation Award
9/9/2009
DeWaay Backs Consumer Health Advisers From Debut VC Fund
8/15/2009
DeWaay launches $10 million venture fund
1/21/2009
I-Bank Taps Debut Fund For KemPharm
11/3/2008
Investing outside the box
Recent/Upcoming Events
May 3-6, 2010
BIO International Convention
May 25-27, 2010
C21 BioVentures™
September 15-17, 2010
BioPharm America™ 2010
©2010 KemPharm, Inc. All rights reserved.
Website
and
logo design
by Logoworks.